Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
601 4 |
Ultima descărcare din IBN: 2022-08-12 13:00 |
Căutarea după subiecte similare conform CZU |
[616.24-002.5+616.36-002]-085:615-06 (1) |
Patologia sistemului respirator. Tulburări ale organelor de respiraţie (757) |
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1732) |
Farmacologie. Terapeutică. Toxicologie (1592) |
SM ISO690:2012 КАДЫРОВА, Агигат Абдул кызы, АХУНДОВА , Ирада Мирсааб кызы. Влияние противотуберкулезного лечения на функцию печени больных с широкой лекарственной устойчивостью с сопутствующими вирусными гепатитами (B и C).. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2019, nr. 3(63), pp. 188-190. ISSN 1857-0011. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale | |||
Numărul 3(63) / 2019 / ISSN 1857-0011 | |||
|
|||
CZU: [616.24-002.5+616.36-002]-085:615-06 | |||
Pag. 188-190 | |||
Descarcă PDF | |||
Rezumat | |||
The purpose of this research is to study the effect of specific XDR-TB therapy on liver function in patients with concomitant viral hepatitis (B and C). The protocols of the Medical Consilium on the treatment of patients with Drug-Resistant Tuberculosis and the results of monitoring the treatment of XDR-TB patients for the period 06.06.2017– 13.06.2019 were analyzed. During this period, 469 patients started the treatment with XDR-TB (346 men, 127 women). The analysis showed that there were 54 XDR-TB patients with concomitant viral hepatitis (B and C). The co-infection with hepatitis B and C is not a contraindication to the prescription of specific therapy for XDR-TB patients. Despite the fact that the drugs used are hepatotoxic, there have been no serious adverse reactions that contribute to the elimination of anti-tuberculosis treatment for XDR-TB patients with hepatitis B and C. An important condition is a thorough examination of the patient before treatment, monitoring the patient’s condition on a monthly basis, timely prescription of treatment, stopping the progression of undesirable reactions arising from the use of anti-tuberculosis drugs from the therapy. |
|||
Cuvinte-cheie tuberculosis, XDR-tuberculosis, hepatitis B, hepatitis C, туберкулез, ШЛУ-туберкулез, гепатит В, гепатит С |
|||
|